| 1. |
- Andronache, M, et al.
(författare)
-
High-resolution Mapping in Patients with Persistent AF
- 2019
-
Ingår i: Arrhythmia & electrophysiology review. - : Radcliffe Group Ltd. - 2050-3369 .- 2050-3377. ; 8:2, s. 111-115
-
Tidskriftsartikel (refereegranskat)abstract
- Ablation of AF through electrical isolation of the pulmonary veins is a well-established technique and a cornerstone in the ablation of AF, although there are a variety of techniques and ablation strategies now available. However, high numbers of patients are returning to hospital after ablation procedures such as pulmonary vein isolation (PVI). Scar tissue (as identified by contact voltage mapping) is found to be present in many of these patients, especially those with persistent AF and even those with paroxysmal AF. This scarring is associated with poor outcomes after PVI. Cardiac mapping is necessary to locate triggers and substrate so that an ablation strategy can be optimised. Multipolar mapping catheters offer more information regarding the status of the tissue than standard ablation catheters. A patient-tailored catheter ablation approach, targeting the patient-specific low voltage/fibrotic substrate can lead to improved outcomes.
|
|
| 2. |
- Blomström-Lundqvist, Carina, et al.
(författare)
-
Redefining the Standard for Atrial Fibrillation : A Patient-centric Report
- 2021
-
Ingår i: ARRHYTHMIA & ELECTROPHYSIOLOGY REVIEW. - : Radcliffe Publishing. - 2050-3369 .- 2050-3377. ; 10:Suppl. 1, s. 1-6
-
Tidskriftsartikel (övrigt vetenskapligt/konstnärligt)abstract
- A roundtable discussion with three European clinical experts in AF and one expert patient diagnosed and treated for AF was conducted in London in October 2019. The panel discussed the implications of AF for patients, current patient pathways, what treatment outcomes were relevant for patients and how the recommendations for the management of AF may change in the future, based on the outcomes of recently published and on-going clinical trials. This article summarises the discussion, and draws upon wider sources to detail best practice and optimal patient treatment pathways.
|
|
| 3. |
- Blomström-Lundqvist, Carina, et al.
(författare)
-
Supraventricular Arrhythmias in Patients with Adult Congenital Heart Disease.
- 2017
-
Ingår i: Arrhythmia & electrophysiology review. - : Radcliffe Group Ltd. - 2050-3369. ; 6:2, s. 42-49
-
Tidskriftsartikel (refereegranskat)abstract
- An increasing number of patients with congenital heart disease survive to adulthood; such prolonged survival is related to a rapid evolution of successful surgical repairs and modern diagnostic techniques. Despite these improvements, corrective atrial incisions performed at surgery still lead to subsequent myocardial scarring harbouring a potential substrate for macro-reentrant atrial tachycardia. Macroreentrant atrial tachycardias are the most common (75 %) type of supraventricular tachycardia (SVT) in patients with adult congenital heart disease (ACHD). Patients with ACHD, atrial tachycardias and impaired ventricular function - important risk factors for sudden cardiac death (SCD) - have a 2-9 % SCD risk per decade. Moreover, ACHD imposes certain considerations when choosing antiarrhythmic drugs from a safety aspect and also when considering catheter ablation procedures related to the inherent cardiac anatomical barriers and required expertise. Expert recommendations for physicians managing these patients are therefore mandatory. This review summarises current evidence-based developments in the field, focusing on advances in and general recommendations for the management of ACHD, including the recently published recommendations on management of SVT by the European Heart Rhythm Association.
|
|
| 4. |
|
|
| 5. |
- Katritsis, Demosthenes G, et al.
(författare)
-
Executive Summary : European Heart Rhythm Association Consensus Document on the Management of Supraventricular Arrhythmias
- 2016
-
Ingår i: Arrhythmia & electrophysiology review. - 2050-3369. ; 5:3, s. 210-224
-
Tidskriftsartikel (refereegranskat)abstract
- This paper is an executive summary of the full European Heart Rhythm Association (EHRA) consensus document on the management of supraventricular arrhythmias, published in Europace. It summarises developments in the field and provides recommendations for patient management, with particular emphasis on new advances since the previous European Society of Cardiology guidelines. The EHRA consensus document is available to read in full at http://europace.oxfordjournals.org.
|
|
